Author

Katy J. McCann

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Tumor DNA methylation subtypes and expression levels of CFISH predict response and overall survival to immunochemotherapy.

BACKGROUND Predicting patient response to immunochemotherapy is vital but challenging and poorly studied in the (neo)adjuvant setting. We showed that tumor monocyte content (TMC) predicts overall survival of advanced esophageal cancer (OC) in response to immunochemotherapy. We report clinical outcomes of 35 operable OC...

Hannah Fuchs, Phil F. Xie, Sabrina A. James et al. · i Medicina · 0 citations

Open access Aug 2026

Identification of pre-existing ubiquitous neoantigen-reactive tumor-infiltrating T-cells in a patient with metastatic pancreatic neuroendocrine tumor

Direct evidence is provided that a single ubiquitous mutation-derived neoantigen can generate systemic T-cell responses and clonotype expansion across multiple metastatic sites in a TMB-low, TIL-low tumor.

J. Tanis, Katy J. McCann, F. E. Castañeda-Castro et al. · bioRxiv · 0 citations